Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in all living cells and is involved in numerous metabolic reactions. It plays a crucial role in cellular energy production, particularly in the processes of glycolysis, the citric acid cycle (Krebs cycle), and oxidative phosphorylation. NAD+ functions as a cofactor for enzymes involved in these metabolic pathways, helping to transfer electrons and protons during the oxidation-reduction reactions that generate energy in the form of ATP (adenosine triphosphate).

The global Nicotinamide adenine dinucleotide (NAD+) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime, Inc. (LPI) ' newest research report, the “Nicotinamide adenine dinucleotide (NAD+) Industry Forecast” looks at past sales and reviews total world Nicotinamide adenine dinucleotide (NAD+) sales in 2023, providing a comprehensive analysis by region and market sector of projected Nicotinamide adenine dinucleotide (NAD+) sales for 2024 through 2030. With Nicotinamide adenine dinucleotide (NAD+) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nicotinamide adenine dinucleotide (NAD+) industry.

This Insight Report provides a comprehensive analysis of the global Nicotinamide adenine dinucleotide (NAD+) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nicotinamide adenine dinucleotide (NAD+) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nicotinamide adenine dinucleotide (NAD+) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nicotinamide adenine dinucleotide (NAD+) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nicotinamide adenine dinucleotide (NAD+).

United States market for Nicotinamide adenine dinucleotide (NAD+) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. China market for Nicotinamide adenine dinucleotide (NAD+) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Europe market for Nicotinamide adenine dinucleotide (NAD+) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Nicotinamide adenine dinucleotide (NAD+) players cover Chromadex, Kingdomway, GeneHarbor, CELFULL, MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Nicotinamide adenine dinucleotide (NAD+) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Purity＞98%
• Purity≤98%

Segmentation by Application:

• Health Care Products
• Beauty Products
• Others

Market by Region:

• Americas
• APAC
• Europe
• Middle East & Africa

Company's Coverage:

• Chromadex
• Kingdomway
• GeneHarbor
• CELFULL
• MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical)
• Bontac
• Herbalmax
• Maac10 Formulas
• EffePharm
• Elysium Health
• Genex Formulas
• NOMON Co., Ltd. (Teijin)
• EZZ

Key Questions Addressed in this Report:

• What is the 10-year outlook for the global Nicotinamide adenine dinucleotide (NAD+) market?
• What factors are driving Nicotinamide adenine dinucleotide (NAD+) market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Nicotinamide adenine dinucleotide (NAD+) market opportunities vary by end market size?
• How does Nicotinamide adenine dinucleotide (NAD+) break out by Type, by Application?